We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note
Read MoreHide Full Article
In the latest close session, Doximity (DOCS - Free Report) was up +1.82% at $44.65. The stock outpaced the S&P 500's daily loss of 0.16%. On the other hand, the Dow registered a loss of 0.09%, and the technology-centric Nasdaq decreased by 0.59%.
The stock of medical social networking site has fallen by 11.63% in the past month, lagging the Medical sector's gain of 1.12% and the S&P 500's loss of 0.21%.
The upcoming earnings release of Doximity will be of great interest to investors. On that day, Doximity is projected to report earnings of $0.44 per share, which would represent a year-over-year decline of 2.22%. Alongside, our most recent consensus estimate is anticipating revenue of $180.66 million, indicating a 7.15% upward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.57 per share and revenue of $644.51 million. These totals would mark changes of +10.56% and +12.99%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Doximity. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Doximity is holding a Zacks Rank of #3 (Hold) right now.
In the context of valuation, Doximity is at present trading with a Forward P/E ratio of 27.93. This indicates a discount in contrast to its industry's Forward P/E of 47.07.
We can additionally observe that DOCS currently boasts a PEG ratio of 1.47. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Medical Info Systems stocks are, on average, holding a PEG ratio of 3.52 based on yesterday's closing prices.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 138, putting it in the bottom 45% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note
In the latest close session, Doximity (DOCS - Free Report) was up +1.82% at $44.65. The stock outpaced the S&P 500's daily loss of 0.16%. On the other hand, the Dow registered a loss of 0.09%, and the technology-centric Nasdaq decreased by 0.59%.
The stock of medical social networking site has fallen by 11.63% in the past month, lagging the Medical sector's gain of 1.12% and the S&P 500's loss of 0.21%.
The upcoming earnings release of Doximity will be of great interest to investors. On that day, Doximity is projected to report earnings of $0.44 per share, which would represent a year-over-year decline of 2.22%. Alongside, our most recent consensus estimate is anticipating revenue of $180.66 million, indicating a 7.15% upward movement from the same quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.57 per share and revenue of $644.51 million. These totals would mark changes of +10.56% and +12.99%, respectively, from last year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Doximity. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Doximity is holding a Zacks Rank of #3 (Hold) right now.
In the context of valuation, Doximity is at present trading with a Forward P/E ratio of 27.93. This indicates a discount in contrast to its industry's Forward P/E of 47.07.
We can additionally observe that DOCS currently boasts a PEG ratio of 1.47. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Medical Info Systems stocks are, on average, holding a PEG ratio of 3.52 based on yesterday's closing prices.
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 138, putting it in the bottom 45% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.